Results 21 to 30 of about 1,395 (139)

National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients [PDF]

Journal of Scleroderma and Related Disorders
Haley J Havrilla, Kathryn S Torok
exaly   +2 more sources

Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma. [PDF]

Arthritis Care Res (Hoboken), 2017
ObjectiveLocalized scleroderma can negatively affect children's quality of life (QoL), but predictors of impact have not been well described. We sought to identify predictors of QoL impact in juvenile localized scleroderma patients.MethodsWe analyzed longitudinal data from a single‐center cohort of juvenile localized scleroderma patients, using ...
Ardalan K, Zigler CK, Torok KS.
europepmc   +4 more sources

Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies [PDF]

Pediatric Rheumatology Online Journal, 2012
Li Suzanne C, Fuhlbrigge Robert C, Dedeoglu Fatma, Ferguson Polly J, Higgins Gloria C, Hong Sandy D, Jacobe Heidi, Lasky Andrew, Laxer Ronald M, Morris Mimi C, Pope Elena, Rabinovich C, Torok Kathryn S   +12 more
doaj   +2 more sources

Neurological and psychological aspects of scleroderma of the face and neck in children

Лечащий Врач, 2021
In the structure of morbidity, among rheumatic diseases in children, juvenile scleroderma takes the third place in frequency after juvenile idiopathic arthritis and systemic lupus erythematosus.
M. S. Pavlova, L. G. Khachatryan, M. K. Osminina, N. A. Geppe, N. S. Podchernyaeva, V. M. Trepilets, M. D. Bogdanova, E. V. Kasanave, E. N. Tjurina, M. D. Velikoretskaya   +9 more
doaj   +1 more source

Localized scleroderma in children

Przegląd Dermatologiczny, 2020
Localized scleroderma is an autoimmune disease affecting the dermis and underlying tissues (subcutaneous tissue, fascia, muscles, bones). The disease mainly occurs in women aged 20–50 years; however, children aged 7–10 years represent about 15% of all ...
Katarzyna A. Wolska-Gawron, Dorota Krasowska   +1 more
doaj   +1 more source

Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics

Вопросы современной педиатрии, 2020
The localized scleroderma (morphea) is the clinical option of the juvenile scleroderma, the third in prevalence rheumatic condition in pediatrics. The article summarizes all the data on the classification, diagnostics, and differential diagnosis of ...
Rinat K. Raupov, Artur I. Imelbaev, Mikhail M. Kostik   +2 more
doaj   +1 more source

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma [PDF]

Pediatric Rheumatology Online Journal, 2008
Osminina MK, Geppe NA, Tougarinova GV, Rabieva GM, Kostina YO   +4 more
doaj   +2 more sources

Juvenile localized scleroderma: clinical picture, diagnosis, therapeutic update (literature review and own observations)

Zdorovʹe Rebenka, 2019
Among rheumatic diseases in children, a special place belongs to juvenile localized scleroderma, which is highlighted as a separate form in the structure of scleroderma diseases and is characterized by: the onset of the disease up to 16 years, skin ...
L.F. Bogmat, V.V. Nikonova
doaj   +1 more source

Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives

Pediatric Rheumatology Online Journal, 2023
Background Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare pediatric conditions often associated with severe morbidities. Delays in diagnosis are common, increasing the risk for permanent damage and worse outcomes.
Leigh A. Stubbs, Andrew M. Ferry, Danielle Guffey, Christina Loccke, Erin Moriarty Wade, Pamela Pour, Kaveh Ardalan, Peter Chira, Ingrid M. Ganske, Daniel Glaser, Gloria Higgins, Nadia Luca, Katharine F. Moore, Vidya Sivaraman, Katie Stewart, Natalia Vasquez-Canizares, Raegan D. Hunt, Renata S. Maricevich, Kathryn S. Torok, Suzanne C. Li, Childhood Arthritis, Rheumatology Research Alliance (CARRA) Scleroderma Workgroup   +20 more
doaj   +1 more source

Research Progress on Pathogenesis and Treatment of Juvenile Localized Scleroderma

Xiehe Yixue Zazhi, 2022
Juvenile localized scleroderma (JLS) is a rare autoimmune disease in children. The lack of specificity in the early symptoms of JLS makes it easy to be misdiagnosed and missed, which leads to the continuous progression of the lesions, and even causes ...
YANG Jingyi, XU Qianyue, YU Hong
doaj   +1 more source